Alligator Bioscience AB (publ)

OM:ATORX Stock Report

Market Cap: SEK 45.6m

Alligator Bioscience Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Søren Bregenholt

Chief executive officer

SEK 5.2m

Total compensation

CEO salary percentage75.63%
CEO tenure4.4yrs
CEO ownershipn/a
Management average tenure1.3yrs
Board average tenure4yrs

Recent management updates

Recent updates

Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

Dec 01
Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

We're Keeping An Eye On Alligator Bioscience's (STO:ATORX) Cash Burn Rate

Dec 21
We're Keeping An Eye On Alligator Bioscience's (STO:ATORX) Cash Burn Rate

Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Jul 30
Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

CEO Compensation Analysis

How has Søren Bregenholt's remuneration changed compared to Alligator Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-SEK 78m

Jun 30 2025n/an/a

-SEK 132m

Mar 31 2025n/an/a

-SEK 179m

Dec 31 2024SEK 5mSEK 4m

-SEK 234m

Sep 30 2024n/an/a

-SEK 248m

Jun 30 2024n/an/a

-SEK 234m

Mar 31 2024n/an/a

-SEK 249m

Dec 31 2023SEK 5mSEK 4m

-SEK 249m

Sep 30 2023n/an/a

-SEK 232m

Jun 30 2023n/an/a

-SEK 231m

Mar 31 2023n/an/a

-SEK 213m

Dec 31 2022SEK 4mSEK 3m

-SEK 193m

Sep 30 2022n/an/a

-SEK 177m

Jun 30 2022n/an/a

-SEK 163m

Mar 31 2022n/an/a

-SEK 152m

Dec 31 2021SEK 4mSEK 2m

-SEK 142m

Compensation vs Market: Søren's total compensation ($USD553.17K) is above average for companies of similar size in the Swedish market ($USD292.63K).

Compensation vs Earnings: Søren's compensation has increased whilst the company is unprofitable.

CEO

Søren Bregenholt (54 yo)

4.4yrs
Tenure
SEK 5,244,000
Compensation

Mr. Søren Bregenholt, Ph D serves as the Chief Executive Officer at Alligator Bioscience AB (publ) since June 01, 2021. He served as the Chief Operating Officer of Symphogen A/S.Mr. Bregenholt served as S...

Leadership Team

NamePositionTenureCompensationOwnership
Søren Bregenholt
Chief Executive Officer4.4yrsSEK 5.24mno data
Johan Gileus
Chief Financial Officer1.3yrsno datano data
Greta Eklund
Investor Relations & Communications Managerno datano datano data
Tom Moore
Chief Medical Officerless than a yearno datano data
Yago de Coana
Medical Science Directorno datano datano data
1.3yrs
Average Tenure

Experienced Management: ATORX's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Hans-Peter Ostler
Chairman of the board4.4yrsSEK 525.00k7.84%
SEK 3.6m
Denise Goode
Independent Director3.5yrsSEK 325.00kno data
Eva Saers
Independent Director4.4yrsSEK 350.00kno data
Karin Nordbladh
Employee Representative Director2.8yrsno datano data
4.0yrs
Average Tenure
58.5yo
Average Age

Experienced Board: ATORX's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/18 15:41
End of Day Share Price 2025/11/18 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alligator Bioscience AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carl RamaniusRedeye
Filip LindkvistRedeye